A Single-Arm, Multicenter, Open-Label Phase Ib/II Clinical Study on the Application of Linperlisib Plus the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs Linperlisib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 04 Feb 2025 New trial record